Home - Products - Metabolic Enzyme/Protease - Dehydrogenase - 6PGD-IN-S3

6PGD-IN-S3

CAS No. 5539-66-2

6PGD-IN-S3( 6PGD Inhibitor S3 | S3 | Danthron methyl derivative )

Catalog No. M27840 CAS No. 5539-66-2

6PGD-IN-S3 is an inhibitor of 6-phosphogluconate dehydrogenase (6PGD).

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	28	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

6PGD-IN-S3
Note

Research use only, not for human use.
Brief Description

6PGD-IN-S3 is an inhibitor of 6-phosphogluconate dehydrogenase (6PGD).
Description

6PGD-IN-S3 is an inhibitor of 6-phosphogluconate dehydrogenase (6PGD).
In Vitro

——
In Vivo

——
Synonyms

6PGD Inhibitor S3 | S3 | Danthron methyl derivative
Pathway

Metabolic Enzyme/Protease
Target

Dehydrogenase
Recptor

——
Research Area

——
Indication

——

Chemical Information

CAS Number

5539-66-2
Formula Weight

254.241
Molecular Formula

C15H10O4
Purity

>98% (HPLC)
Solubility

——
SMILES

COc1cccc2C(=O)c3cccc(O)c3C(=O)c12
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.H Kikukawa, et al. Production of cis-11-eicosenoic acid by Mortierella fungi. J Appl Microbiol. 2015 Mar;118(3):641-7.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

11β-HSD1-IN-1

11β-HSD1-IN-1 is an inhibitor of 11β-hydroxydehydrogenase 1 (11β-HSD1, IC50: 52 nM) used for the treatment of pain.
JC2-11

JC2-11 is an inhibitory compound for inflammation.JC2-11 inhibits the recruitment domain-containing proteins NLRC 4, atypical in melanoma 2 (AIM 2) and atypical (NC) inflammatory vesicles by disrupting reactive oxygen species (ROS) production and caspase-1 activity.
GSK321

GSK321 is a selective and potent mutant isocitrate dehydrogenase 1 (IDH1) inhibitor that inhibits lipid synthesis and blocks cell proliferation in OPA1-deficient MEFs and prevents cytoplasmic glutamine reductive carboxylation.GSK321 has been used in the study of leukemia.

Sign In Join Free